» Articles » PMID: 36033707

Exploring Highly Functionalized Tetrahydropyridine As a Dual Inhibitor of Monoamine Oxidase A and B: Synthesis, Structural Analysis, Single Crystal XRD, Supramolecular Assembly Exploration by Hirshfeld Surface Analysis, and Computational Studies

Overview
Journal ACS Omega
Specialty Chemistry
Date 2022 Aug 29
PMID 36033707
Authors
Affiliations
Soon will be listed here.
Abstract

Ethyl 4-(4-fluorophenylamino)-2,6-bis(4-(trifluoromethyl)phenyl)-1-(4-fluoro-phenyl)-1,2,5,6-tetrahydropyridine-3-carboxylate () has been synthesized efficiently in an iodine-catalyzed five-component reaction of 4-fluoroaniline, 4-trifluoromethyl benzaldehyde, and ethyl acetoacetate in methanol at 55 °C for 12 h. Various spectro-analytical techniques such as H and C NMR and Fourier-transform infrared spectroscopy have validated the structure of . Further confirmation of the structure of has been established on the basis of single-crystal X-ray diffraction analysis. The supramolecular assembly of in terms of strong and comparatively weak noncovalent interactions is fully investigated by Hirshfeld surface analysis, the interaction energy between pairs of molecules, and energy frameworks. The void analysis is conducted to explore the strength and stability of the crystal structure. Furthermore, molecular docking analysis was computationally performed to see the potential intermolecular interactions between the selected proteins and . The binding interaction energies are found to be -8.8 and -9.6 kcal/mol for the proteins MAO-B (PDB ID: 2V5Z) and MAO-A (PDB ID: 2Z5X), respectively. These reasonably good binding energies (more negative values) indicate the efficient associations between the and target proteins. The proteins and were also analyzed for intermolecular interactions. and proteins interact in a variety of ways, like conventional hydrogen bonds, carbon-hydrogen bonds, alkyl, π-alkyl, and halide interactions.

Citing Articles

Synthesis, DFT and molecular docking of novel (Z)-4-bromo-N-(4-butyl-3 (quinolin-3-yl)thiazol-2(3H)-ylidene)benzamide as elastase inhibitor.

Mustafa M, Ali Channar P, Ejaz S, Afzal S, Aziz M, Shamim T BMC Chem. 2023; 17(1):95.

PMID: 37550776 PMC: 10408170. DOI: 10.1186/s13065-023-00985-4.


Synthesis, Characterization, Crystal Structures, and Supramolecular Assembly of Copper Complexes Derived from Nitroterephthalic Acid along with Hirshfeld Surface Analysis and Quantum Chemical Studies.

Hasanova S, Yolchueva E, Mashadi A, Muhammad S, Ashfaq M, Muhammed M ACS Omega. 2023; 8(9):8530-8540.

PMID: 36910960 PMC: 9996808. DOI: 10.1021/acsomega.2c07686.

References
1.
Mackenzie C, Spackman P, Jayatilaka D, Spackman M . model energies and energy frameworks: extension to metal coordination compounds, organic salts, solvates and open-shell systems. IUCrJ. 2017; 4(Pt 5):575-587. PMC: 5600021. DOI: 10.1107/S205225251700848X. View

2.
Pires D, Blundell T, Ascher D . pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J Med Chem. 2015; 58(9):4066-72. PMC: 4434528. DOI: 10.1021/acs.jmedchem.5b00104. View

3.
Raza H, Yildiz I, Yasmeen F, Munawar K, Ashfaq M, Abbas M . Synthesis of a 2D copper(II)-carboxylate framework having ultrafast adsorption of organic dyes. J Colloid Interface Sci. 2021; 602:43-54. DOI: 10.1016/j.jcis.2021.05.169. View

4.
Spek A . Structure validation in chemical crystallography. Acta Crystallogr D Biol Crystallogr. 2009; 65(Pt 2):148-55. PMC: 2631630. DOI: 10.1107/S090744490804362X. View

5.
Funakoshi T, Chaki S, Kawashima N, Suzuki Y, Yoshikawa R, Kumagai T . In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic. Life Sci. 2002; 71(12):1371-84. DOI: 10.1016/s0024-3205(02)01863-5. View